Colonoscopy is examination of the inside of the colon using a colonoscope, inserted into the rectum. A colonoscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue to be checked under a microscope for signs of disease.
In its latest recommendations, the US Multi-Society Task Force on Colorectal Cancer Screening confirms that people at average risk should be screened beginning at age 50, and recommends colonoscopy and fecal immunochemical testing as the "first tier" screening tests for this group.
While many men struggle to be their own health advocate, Father's Day provides the perfect reminder for families to step up and encourage dad to take care of himself.
During colonoscopy screening for bowel cancer and in the four weeks after the procedure, the risk for complications to develop is low.
University of Alabama at Birmingham researchers have made the first direct demonstration that fecal donor microbes remained in recipients for months or years after a transplant to treat the diarrhea and colitis caused by recurrent Clostridium difficile infections -- a serious and stubborn cause of diarrhea after an antibiotic treatment for some other illness.
In humans, developing metabolic disease, particularly type 2 diabetes, is correlated with having bacteria that penetrate the mucus lining of the colon, according to a study led by Drs. Benoit Chassaing and Andrew Gewirtz at Georgia State University.
University of North Carolina Lineberger Comprehensive Cancer Center researchers have identified a strategy that doubled screening rates for colorectal cancer, the second leading cause of cancer death in the United States, among patient groups who historically have had lower rates.
Minimally invasive endoscope using breakthrough photonics technology to enable rapid, accurate diagnosis of bowel polyps and early colon cancer.
A single transplant of microbes contained in the stool of a healthy donor is a safe and effective way to increase diversity of good bacteria in the guts of patients with ulcerative colitis, according to new research from Weill Cornell Medicine and NewYork-Presbyterian.
Very common – most of us will experience bowel symptoms from time to time, but usually the symptoms last only a few days. You should see your GP if they persist for more than three weeks (sooner if they are severe) or if your symptoms keep coming back.
For some baby boomers, getting ready for a routine visit with their doctor is like training for a marathon. Some patients want to be in the best shape possible before stepping on that scale and getting those lab results.
The type of bacteria in your gut may help diagnose colorectal cancer. Researchers at Baylor College of Medicine and other institutions have identified specific types of bacteria that seem to be abundant in individuals with colorectal cancer.
The rate of new cases of bowel cancer in Austria has fallen by around 20% in the last ten years, while the associated mortality rate has fallen by nearly 30%.
Specific strains of bacteria in the gut are significantly associated with colorectal cancer, according to a new study by researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
Synthetic biologists at Rice University have engineered gut bacteria capable of sensing colitis, an inflammation of the colon, in mice.
Colorectal cancer is a combined term to describe the malignant tumors that occur in the large intestine; the colon being the upper part of the large intestine and the rectum being the lowest part of the large intestine.
A patient's confidence in their ability to schedule, plan for and properly conduct their part in colorectal screening methods is a key factor that predicts whether they intend to be tested, according to new research from Penn State College of Medicine. The findings suggest that educating patients could improve screening rates.
The University of Exeter, in partnership with Bowel Cancer UK Never Too Young campaign, Durham University and North Tees and Hartlepool NHS Foundation Trust, today publishes in the British Journal of General Practice a new research and risk assessment tool.
Colorectal cancer is the second leading cause of cancer death for men and women in the United States according to the American Cancer Society.
A new analysis reveals a relatively high rate of colon cancer screening among US patients on dialysis, even though they rarely stand to benefit from such screening. The findings appear in an upcoming issue of the Journal of the American Society of Nephrology.
Blood tests that could detect cancer before it develops show promise for the future of screening and prevention, though researchers continue to test which cancer clues are good markers for diagnosis.